Logo
Aveo Pharmaceuticals Inc

Director, Distribution and GPOs

Aveo Pharmaceuticals Inc, Boston, Massachusetts, us, 02298


JOB SUMMARY:

The Director, Distribution and GPOs is responsible for developing and executing strategic trade plans for assigned accounts to support the successful commercialization of AVEO's lead oncology pipeline agent, Fotivda (tivozanib). This role will serve as the primary contact between AVEO and designated trade and distribution partners. The Director, Distribution and GPOs, will lead all account initiatives and is responsible for achieving expected business objectives across the oncology portfolio of Aveo products. This role will collaborate with multiple stakeholders including sales, marketing, market access, medical affairs, HEOR, compliance/legal and finance to ensure successful commercialization of products within the oncology pipeline.

PRINCIPAL DUTIES:

Develop, define, and implement account strategy and objectives for the continued successful commercialization of Fotivda (tivozanib) and potential future product launches.

Ensure strong business relationships with assigned accounts

Execute action plans to compliantly maximize market access for Aveo products

Collaborate with sales, marketing, finance, legal/compliance, medical affairs and market access to optimize strategic opportunities and initiatives

Contribute effectively to pricing and contracting strategy development

Effectively communicate account positioning with internal stakeholders regularly

Continually assess the competitive landscape and adjust strategies and tactics accordingly

Manage budgeted items and responsibilities for understanding of overall gross to net impact

Monitor trends and potential coverage and reimbursement issues, existing and emerging government and payer policies, competitive pricing and contracting strategies, and potential barriers to provider and patient access.

REQUIRED QUALIFICATIONS/EXPERIENCE (BASIC QUALIFICATIONS):

Minimum of a bachelor's degree; advanced degree preferred

10+ years of progressive experience within sales, marketing, or managed markets roles in account management, formulary access, reimbursement, distribution, program development, contract negotiations and policy development

At least 5 years of successful oncology account or sales management experience

Previous new product launch experience in Oncology

Strong knowledge of distributor channel and GPO services

Fluently understand the business of oncology, distribution, discounting, contracting and reimbursement

Experience and understanding of oral oncology product access channels

Strong understanding of relevant health care laws, including anti-kickback statute and false claims act, to ensure compliant contracting

Experience in contract strategy development

Ability to negotiate effective contract positioning and decisions with assigned account.

Self-motivated, assertive, and self-confident with the ability to act with urgency and passion

Proven ability to work with high level of integrity, accuracy, and attention to detail

Strong organizational skills to maintain a high level of productivity, innovation, and prioritizing to complete assignments on time and within budget

Ability to make thoughtful, timely and meaningful decisions to take corresponding actions

Resourceful, creative, enthusiastic, innovative and results oriented

Flexible, adaptable, diplomatic, and able to effectively manage through ambiguity

Entrepreneurial, enjoys working in a fast paced, small company environment

Effective budget development and management skills; ability to collaborate cross functionally

Strong interpersonal and teambuilding skills

Willingness to travel and attend industry meetings as needed

High proficiency with Microsoft Office, Excel, Powerpoint

About AVEO

AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has several other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company.

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.